Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.
S Yamashita, … , S Tarui, D Y Hui
S Yamashita, … , S Tarui, D Y Hui
Published September 1, 1990
Citation Information: J Clin Invest. 1990;86(3):688-695. https://doi.org/10.1172/JCI114764.
View: Text | PDF
Research Article

Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.

  • Text
  • PDF
Abstract

This study characterized the plasma lipoproteins of familial hyperalphalipoproteinemic patients with or without deficiency of cholesteryl ester transfer protein (CETP) activity. The subjects with CETP deficiency have increased levels of apolipoprotein (apo) E. The increased concentration of apo E in these subjects was correlated to the appearance of apo E-rich high density lipoproteins (HDL). Sodium dodecyl sulfate-polyacrylamide gel analysis revealed that these lipoproteins contained predominantly the apo E (82%) and little amount of apo A-I (18%). These apo E-rich HDL displayed a much higher affinity than human LDL in binding to LDL receptors on human fibroblasts. Furthermore, 3.5 times fewer apo E-rich HDL than LDL were required to saturate the receptors on fibroblasts. These data indicated that the apo E-rich HDL in CETP-deficient human subjects contained multiple copies of apo E and bound to the LDL receptor through multiple interactions. The apo E-rich HDL, with similar properties as cholesterol-induced apo E HDLc, were not detectable in normal human subjects or in hyperalphalipoproteinemic subjects with normal CETP activity. The apo E-containing HDL in the latter subjects were smaller and contained only small amounts of apo E (14%). The difference in apo E-containing HDL in these subjects suggests a correlation between CETP level and the appearance of apo E-rich HDL.

Authors

S Yamashita, D L Sprecher, N Sakai, Y Matsuzawa, S Tarui, D Y Hui

×

Total citations by year

Year: 2023 2022 2021 2019 2018 2017 2016 2015 2014 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1983 Total
Citations: 1 2 2 4 5 4 2 2 2 5 3 3 3 3 1 3 1 6 7 6 3 4 2 3 6 6 13 11 16 4 10 1 144
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (144)

Title and authors Publication Year
Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides.
Higashi Y
Cells 2023
HDL Receptor in Schistosoma japonicum Mediating Egg Embryonation: Potential Molecular Basis for High Prevalence of Cholesteryl Ester Transfer Protein Deficiency in East Asia.
Yokoyama S
Frontiers in Cell and Developmental Biology 2022
Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans
Brodeur MR, Rhainds D, Charpentier D, Boulé M, Mihalache-Avram T, Mecteau M, Brand G, Pedneault-Gagnon V, Fortier A, Niesor EJ, Rhéaume E, Maugeais C, Tardif JC
Journal of lipid research 2022
Is a High HDL-Cholesterol Level Always Beneficial?
B Franczyk, J Rysz, J Ławiński, M Rysz-Górzyńska, A Gluba-Brzózka
Biomedicines 2021
Role of Genetics in Preventive Cardiology: Focused on Dyslipidemia
SH Lee
Korean Circulation Journal 2021
The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance
Melinde Wijers, Paolo Zanoni, Nalan Liv, Dyonne Y. Vos, Michelle Y Jäckstein, Marieke Smit, Sanne Wilbrink, Justina C. Wolters, Ydwine Y.T. van der Veen, N.C.A. Huijkman, Daphne Dekker, Niels J Kloosterhuis, Theo H. van Dijk, Daniel Billadeau, Folkert Kuipers, Judith Klumperman, Arnold von Eckardstein, Jan Albert Kuivenhoven, Bart van de Sluis
JCI Insight 2019
Comparing Data-Independent Acquisition and Parallel Reaction Monitoring in Their Abilities To Differentiate High-Density Lipoprotein Subclasses
AR Silva, MT Toyoshima, M Passarelli, PD Mascio, GE Ronsein
Journal of Proteome Research 2019
Association of extremely high levels of high-density lipoprotein cholesterol with endothelial dysfunction in men
Y Takaeko, S Matsui, M Kajikawa, T Maruhashi, S Kishimoto, H Hashimoto, Y Kihara, E Hida, K Chayama, C Goto, Y Aibara, FM Yusoff, K Noma, A Nakashima, Y Higashi
Journal of Clinical Lipidology 2019
Shotgun proteomic analysis reveals proteome alterations in HDL of patients with cholesteryl ester transfer protein deficiency
T Okada, T Ohama, K Takafuji, K Kanno, H Matsuda, M Sairyo, Y Zhu, A Saga, T Kobayashi, D Masuda, M Koseki, M Nishida, Y Sakata, S Yamashita
Journal of Clinical Lipidology 2019
FoxO Transcription Factors are Required for Hepatic HDL-Cholesterol Clearance
Samuel Lee, Markus Heine, Christian Schlein, Rajasekhar Ramakrishnan, Jing Liu, Gabriella Belnavis, Ido Haimi, Alexander W. Fischer, Henry Ginsberg, Joerg Heeren, Franz Rinninger, Rebecca A. Haeusler
Journal of Clinical Investigation 2018
Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency
T Okada, T Ohama, M Okazaki, K Kanno, H Matsuda, M Sairyo, Y Zhu, A Saga, T Kobayashi, D Masuda, M Koseki, M Nishida, Y Sakata, S Yamashita, P Aspichueta
PloS one 2018
Present therapeutic role of cholesteryl ester transfer protein inhibitors
N Ferri, A Corsini, CR Sirtori, M Ruscica
Pharmacological research : the official journal of the Italian Pharmacological Society 2018
A two-step homogeneous assay for apolipoprotein E-containing high-density lipoprotein-cholesterol
Y Takahashi, Y Ito, T Sakurai, N Wada, A Nagasaka, M Fujikawa, H Chiba, SP Hui
Annals of Clinical Biochemistry 2018
High density lipoprotein cholesterol and proteome in SR-B1 KO mice: lost in precipitation
S Contreras-Duarte, N Santander, R Birner-Gruenberger, C Wadsack, A Rigotti, D Busso
Journal of Translational Medicine 2018
Comparative studies of three cholesteryl ester transfer proteins and their interactions with known inhibitors
Z Wang, M Niimi, Q Ding, Z Liu, L Wang, J Zhang, J Xu, J Fan, I Tancevski
PloS one 2017
The role of paraoxonase 1 in regulating high-density lipoprotein functionality during aging
A Khalil, OK Simo, S Ikhlef, H Berrougui
Canadian Journal of Physiology and Pharmacology 2017
Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk: A community-based cohort study
Y Qi, J Liu, W Wang, M Wang, F Zhao, J Sun, J Liu, D Zhao
Journal of Clinical Lipidology 2017
Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in RabbitsHighlights
J Zhang, M Niimi, D Yang, J Liang, J Xu, T Kimura, AV Mathew, Y Guo, Y Fan, T Zhu, J Song, R Ackermann, Y Koike, A Schwendeman, L Lai, S Pennathur, M Garcia-Barrio, J Fan, YE Chen
Arteriosclerosis, thrombosis, and vascular biology 2017
Development of homogeneous assay for simultaneous measurement of apoE-deficient, apoE-containing, and total HDL-cholesterol
Y Takahashi, Y Ito, N Wada, A Nagasaka, M Fujikawa, T Sakurai, R Shrestha, SP Hui, H Chiba
Clinica Chimica Acta 2016
Analysis of lipoprotein profiles of healthy cats by gel-permeation high-performance liquid chromatography
H MIZUTANI, T SAKO, H OKUDA, N ARAI, K KURIYAMA, A MORI, I YOSHIMURA, H KOYAMA
Journal of Veterinary Medical Science 2016
Unique Features of High-Density Lipoproteins in the Japanese: In Population and in Genetic Factors
S Yokoyama
Nutrients 2015
Prevention of fatal hepatic complication in schistosomiasis by inhibition of CETP
Shinji Yokoyama, Kuniko Okumura-Noji, Rui Lu
Journal of Biomedical Research 2015
A potential screening factor for accumulation of cholesteyl ester transfer protein deficiency in East Asia: Schistosoma japonicum
S Yokoyama
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2014
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes
2014
Modulation of lipid metabolism with the overexpression of NPC1L1 in mouse liver[S]
M Kurano, M Hara, K Tsuneyama, K Okamoto, N Iso-O, T Matsushima, K Koike, K Tsukamoto
Journal of lipid research 2012
Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
S Kunnen, MV Eck
Journal of lipid research 2012
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Cholestasis Causes Discrepancy in HDL-Cholesterol Levels Measured Using Various Methods
S Kim, S Chun, W Lee, GS Kim, WK Min
Laboratory Medicine Online 2012
Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
S Kunnen, MV Eck
Journal of lipid research 2012
HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events
RS Rosenson, HB Brewer, MJ Chapman, S Fazio, MM Hussain, A Kontush, RM Krauss, JD Otvos, AT Remaley, EJ Schaefer
Clinical chemistry 2011
Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism
EJ Niesor
Current Opinion in Lipidology 2011
Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction
DE Gutstein, R Krishna, D Johns, HK Surks, HM Dansky, S Shah, YB Mitchel, J Arena, JA Wagner
Clinical Pharmacology & Therapeutics 2011
Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib
L Yvan-Charvet, J Kling, T Pagler, H Li, B Hubbard, T Fisher, CP Sparrow, AK Taggart, AR Tall
Arteriosclerosis, thrombosis, and vascular biology 2010
The HDL Handbook
NJ Hime
The HDL Handbook 2010
Formes rares de dyslipidémies génétiques
G Luc
EMC - Endocrinologie - Nutrition 2010
Association of ApoE and HDL-C with cardiovascular and cerebrovascular disease: potential benefits of LDL-apheresis therapy
PM Moriarty
Clinical Lipidology 2009
Pharmacokinetic, Pharmacodynamic, and Safety Profile of a New Cholesteryl Ester Transfer Protein Inhibitor in Healthy Human Subjects
R Wolk, D Chen, RW Clark, J Mancuso, PL Barclay
Clinical Pharmacology & Therapeutics 2009
Lessons Learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial
P Barter
The American Journal of Cardiology 2009
Peroxisome Proliferator-Activated Receptor α Agonists Regulate Cholesterol Ester Transfer Protein
TP Beyer, Y Chen, RK Porter, D Lu, RJ Schmidt, NB Mantlo, RJ Konrad, G Cao
Lipids 2008
HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis
AR Tall, L Yvan-Charvet, N Terasaka, T Pagler, N Wang
Cell Metabolism 2008
Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency
A Inazu, K Nakajima, T Nakano, M Niimi, M Kawashiri, A Nohara, J Kobayashi, H Mabuchi
Atherosclerosis 2008
Functional LCAT deficiency in human apolipoprotein A-I transgenic, SR-BI knockout mice
JY Lee, RM Badeau, A Mulya, E Boudyguina, AK Gebre, TL Smith, JS Parks
Journal of lipid research 2007
HDL from CETP deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway
Fumihiko Matsuura, Nan Wang, Wengen Chen, Xian-Cheng Jiang, Alan R. Tall
Journal of Clinical Investigation 2006
Putting cholesterol in its place: apoE and reverse cholesterol transport
RW Mahley, Y Huang, KH Weisgraber
Journal of Clinical Investigation 2006
Altered lipid, apolipoprotein, and lipoprotein profiles in inflammatory bowel disease: consequences on the cholesterol efflux capacity of serum using Fu5AH cell system
BR Piquer, H Nazih, A Bourreille, JP Segain, JM Huvelin, JP Galmiche, JM Bard
Metabolism 2006
Effect of cholesteryl ester transfer protein (CETP) expression on diet-induced hyperlipidemias in transgenic rats
Z Zak, T Gautier, L Dumont, D Masson, V Deckert, L Duverneuil, JP de Barros, NL Guern, M Schneider, P Moulin, A Bataillard, L Lagrost
Atherosclerosis 2005
Inhibition of cholesteryl ester transfer protein activity: A new therapeutic approach to raising high-density lipoprotein
DJ Rader
Current Atherosclerosis Reports 2004
Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia
WL Goff, M Guerin, MJ Chapman
Pharmacology & Therapeutics 2004
Scavenger receptor type BI potentiates reverse cholesterol transport system by removing cholesterol ester from HDL
M Kinoshita, M Fujita, S Usui, Y Maeda, M Kudo, D Hirota, T Suda, M Taki, M Okazaki, T Teramoto
Atherosclerosis 2004
Molecular Mechanisms of Cholesteryl Ester Transfer Protein Deficiency in Japanese
M Nagano, S Yamashita, K Hirano, M Takano, T Maruyama, M Ishihara, Y Sagehashi, T Kujiraoka, K Tanaka, H Hattori, N Sakai, N Nakajima, T Egashira, Y Matsuzawa
Journal of Atherosclerosis and Thrombosis 2004
Hypertriglyceridemia in pregnancy does not contribute to the enhanced formation of remnant lipoprotein particles
M Okazaki, S Usui, K Tokunaga, Y Nakajima, S Takeichi, T Nakano, K Nakajima
Clinica Chimica Acta 2004
Emerging strategies and applications of pharmacogenomics
PM Milos, AB Seymour
Human genomics 2004
HDL: The Metabolism, Function, and Therapeutic Importance
M Wang, MR Briggs
Chemical Reviews 2003
Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia
T Maruyama, N Sakai, M Ishigami, K Hirano, T Arai, S Okada, E Okuda, A Ohya, N Nakajima, K Kadowaki, E Fushimi, S Yamashita, Y Matsuzawa
Atherosclerosis 2003
Enlargement of High Density Lipoprotein in Mice via Liver X Receptor Activation Requires Apolipoprotein E and Is Abolished by Cholesteryl Ester Transfer Protein Expression
XC Jiang, TP Beyer, Z Li, J Liu, W Quan, RJ Schmidt, Y Zhang, WR Bensch, PI Eacho, G Cao
The Journal of biological chemistry 2003
Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency
BF Asztalos, KV Horvath, K Kajinami, C Nartsupha, CE Cox, M Batista, EJ Schaefer, A Inazu, H Mabuchi
Journal of lipid research 2003
Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles
L Krimbou, M Marcil, H Chiba, J Genest
Journal of lipid research 2003
Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis
PJ Barter, HB Brewer, MJ Chapman, CH Hennekens, DJ Rader, AR Tall
Arteriosclerosis, thrombosis, and vascular biology 2003
Lexikon der Syndrome und Fehlbildungen
R Witkowski, O Prokop, E Ullrich, G Thiel
2003
Unique character and metabolism of high density lipoprotein (HDL) in fetus
H Nagasaka, H Chiba, H Kikuta, H Akita, Y Takahashi, H Yanai, SP Hui, H Fuda, H Fujiwara, K Kobayashi
Atherosclerosis 2002
A major gene influences variation in large HDL particles and their response to diet in baboons
DL Rainwater, CM Kammerer, LA Cox, J Rogers, KD Carey, B Dyke, MC Mahaney, HC McGill, JL VandeBerg
Atherosclerosis 2002
Advances in Cell Aging and Gerontology
T Fülöp, K Hirokawa, G Dupuis, A Larbi, G Pawelec
Advances in Cell Aging and Gerontology 2002
Hugh Sinclair Lecture: The regulation and remodelling of HDL by plasma factors
PJ Barter
Atherosclerosis Supplements 2002
Phospholipid Transfer Protein Is Regulated by Liver X Receptors in Vivo
G Cao, TP Beyer, XP Yang, RJ Schmidt, Y Zhang, WR Bensch, RF Kauffman, H Gao, TP Ryan, Y Liang, PI Eacho, XC Jiang
The Journal of biological chemistry 2002
Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL
Z Zak, L Lagrost, T Gautier, D Masson, V Deckert, L Duverneuil, JP de Barros, NL Guern, L Dumont, M Schneider, V Risson, P Moulin, D Autran, G Brooker, J Sassard, A Bataillard
Journal of lipid research 2002
Studies on the plasma lipid profiles, and LCAT and CETP activities according to hyperlipoproteinemia phenotypes (HLP)
M Lee, JQ Kim, J Kim, H Oh, M Park
Atherosclerosis 2001
Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport
Z Zhang, S Yamashita, K Hirano, Y Nakagawa-Toyama, A Matsuyama, M Nishida, N Sakai, M Fukasawa, H Arai, J Miyagawa, Y Matsuzawa
Atherosclerosis 2001
Significance of a Polymorphism (G-^|^gt;A transition) in the -75 Position of the Apolipoprotein A-I Gene Promoter on Serum High Density Lipoprotein-Cholesterol Levels in Japanese Hyperlipidemic Subjects
J Tashiro, N Morisaki, J Kobayashi, H Bujo, T Kanzaki, S Murano, Y Saito
Journal of Atherosclerosis and Thrombosis 2001
Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia
S Yamashita, T Maruyama, K Hirano, N Sakai, N Nakajima, Y Matsuzawa
Atherosclerosis 2000
Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein
S Yamashita
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2000
Pros and cons of inhibiting cholesteryl ester transfer protein
K Hirano, S Yamashita, Y Matsuzawa
Current Opinion in Lipidology 2000
Lipoprotein Metabolism and Atherogenesis
T Kita, M Yokode
2000
Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice
B Föger, M Chase, MJ Amar, BL Vaisman, RD Shamburek, B Paigen, J Fruchart-Najib, JA Paiz, CA Koch, RF Hoyt, HB Brewer, S Santamarina-Fojo
The Journal of biological chemistry 1999
Expression of Human Scavenger Receptor Class B Type I in Cultured Human Monocyte-Derived Macrophages and Atherosclerotic Lesions
K Hirano, S Yamashita, Y Nakagawa, T Ohya, F Matsuura, K Tsukamoto, Y Okamoto, A Matsuyama, K Matsumoto, J Miyagawa, Y Matsuzawa
Circulation research 1999
Advances in Protein Chemistry
CM Silva, J Isgaard, MO Thorner
Advances in Protein Chemistry 1998
Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport
M Dammerman, LA Sandkuijl, JL Halaas, W Chung, JL Breslow
Annual Review of Nutrition 1998
Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport
M Dammerman, LA Sandkuijl, JL Halaas, W Chung, JL Breslow
Annual Review of Nutrition 1998
Fish-eye disease: Structural and in vivo metabolic abnormalities of high-density lipoproteins
L Elkhalil, Z Majd, R Bakir, O Perez-Mendez, G Castro, P Poulain, B Lacroix, N Duhal, JC Fruchart, G Luc
Metabolism 1997
The Role of Cholesteryl Ester Transfer Protein and Phospholipid Transfer Protein in the Remodeling of Plasma High-Density Lipoproteins
L Lagrost
Trends in Cardiovascular Medicine 1997
Cholesteryl Ester Transfer Protein Activity Enhances Plasma Cholesteryl Ester Formation: Studies in CETP Transgenic Mice and Human Genetic CETP Deficiency
HC Oliveira, L Ma, R Milne, SM Marcovina, A Inazu, H Mabuchi, AR Tall
Arteriosclerosis, thrombosis, and vascular biology 1997
Genetic Cholesteryl Ester Transfer Protein Deficiency Is Extremely Frequent in the Omagari Area of Japan: Marked Hyperalphalipoproteinemia Caused by CETP Gene Mutation Is Not Associated With Longevity
K Hirano, S Yamashita, N Nakajima, T Arai, T Maruyama, Y Yoshida, M Ishigami, N Sakai, K Kameda-Takemura, Y Matsuzawa
Arteriosclerosis, thrombosis, and vascular biology 1997
Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency
H Chiba, H Akita, K Tsuchihashi, SP Hui, Y Takahashi, H Fuda, H Suzuki, H Shibuya, M Tsuji, K Kobayashi
Journal of lipid research 1997
Characterization of human plasma apolipoprotein E-containing lipoproteins in the high density lipoprotein size range: focus on pre-beta1-LpE, pre-beta2-LpE, and alpha-LpE
L Krimbou, M Tremblay, J Davignon, JS Cohn
Journal of lipid research 1997
Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats
BR Krause, BC Barnett, AD Essenburg, KA Kieft, BJ Auerbach, R Bousley, R Stanfield, RS Newton, CL Bisgaier
Atherosclerosis 1996
Effect of lipid transfer proteins on lipoprotein lipase induced transformation of VLDL and HDL
SJ Murdoch, WC Breckenridge
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1996
Molecular Disorders of Cholesteryl Ester Transfer Protein
S Yamashita, T Arai, K Hirano, N Sakai, M Ishigami, N Nakajima, Y Matsuzawa
Journal of Atherosclerosis and Thrombosis 1996
Drugs Affecting Lipid Metabolism
AM Gotto, R Paoletti, LC Smith, AL Catapano, AS Jackson
1996
A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects
T Arai, S Yamashita, N Sakai, K Hirano, S Okada, M Ishigami, T Maruyama, M Yamane, H Kobayashi, S Nozaki, T Funahashi, K Kameda-Takemura, N Nakajima, Y Matsuzawa
Journal of lipid research 1996
Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection
N Sakai, S Santamarina-Fojo, S Yamashita, Y Matsuzawa, HB Brewer
Journal of lipid research 1996
Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency
K Ikewaki, M Nishiwaki, T Sakamoto, T Ishikawa, T Fairwell, LA Zech, M Nagano, H Nakamura, HB Brewer, DJ Rader
Journal of Clinical Investigation 1995
Remodelling of lipoproteins in transgenic mice expressing human cholesteryl ester transfer protein
J Dinchuk
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1995
Cholesteryl ester transfer protein inhibition in hypercholesterolemic hamsters: Kinetics of apoprotein changes
SH Zuckerman, GF Evans
Lipids 1995
Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies
AR Tall
Journal of Internal Medicine 1995
Characterization of High-density Apolipoprotein Particles A-I and A-I:A-II Isolated from Humans with Cholesteryl Ester Transfer Protein Deficiency
N Duverger, D Rader, K Ikewaki, M Nishiwaki, T Sakamoto, T Ishikawa, M Nagano, H Nakamura, HB Brewer
European Journal of Biochemistry 1995
Section Review—Cardiovascular & Renal: Emerging Therapies in Atherosclerosis
BR Krause, DR Sliskovic, TM Bocan
Expert Opinion on Investigational Drugs 1995
Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects
N Sakai, S Yamashita, K Hirano, M Menju, T Arai, K Kobayashi, M Ishigami, Y Yoshida, T Hoshino, N Nakajima, K Kameda-Takemura, Y Matsuzawa
Atherosclerosis 1995
Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency
N Sakai, S Yamashita, KI Hirano, M Ishigami, T Arai, K Kobayashi, T Funahashi, Y Matsuzawa
European Journal of Clinical Investigation 1995
Enzyme-linked immunosorbent assay for cholesteryl ester transfer protein in human serum
T Sato, M Fukasawa, M Kinoshita, H Arai, T Saeki, T Naraki, Y Iwasaki, T Teramoto, K Takahashi, Y Saito, K Inoue
Clinica Chimica Acta 1995
Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma
T Murakami, S Michelagnoli, R Longhi, G Gianfranceschi, F Pazzucconi, L Calabresi, CR Sirtori, G Franceschini
Arteriosclerosis, thrombosis, and vascular biology 1995
Apolipoprotein B and E Basic Amino Acid Clusters Influence Low-Density Lipoprotein Association with Lipoprotein Lipase Anchored to the Subendothelial Matrix
U Saxena, BJ Auerbach, E Ferguson, J Wölle, YL Marcel, KH Weisgraber, RA Hegele, CL Bisgaier
Arteriosclerosis, thrombosis, and vascular biology 1995
Atherosclerotic Disease in Marked Hyperalphalipoproteinemia: Combined Reduction of Cholesteryl Ester Transfer Protein and Hepatic Triglyceride Lipase
K Hirano, S Yamashita, Y Kuga, N Sakai, S Nozaki, S Kihara, T Arai, K Yanagi, S Takami, M Menju, M Ishigami, Y Yoshida, K Kameda-Takemura, K Hayashi, Y Matsuzawa
Arteriosclerosis, thrombosis, and vascular biology 1995
Evidence for Nonesterified Fatty Acids as Modulators of Neutral Lipid Transfers in Normolipidemic Human Plasma
L Lagrost, E Florentin, V Guyard-Dangremont, A Athias, H Gandjini, C Lallemant, P Gambert
Arteriosclerosis, thrombosis, and vascular biology 1995
Cholesteryl ester transfer protein inhibition by PD 140195
CL Bisgaier, AD Essenburg, LL Minton, R Homan, CJ Blankley, A White
Lipids 1994
Drug control of reverse cholesterol transport
G Franceschini, JP werba, L Calabresi
Pharmacology & Therapeutics 1994
Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies
L Lagrost
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1994
Determination of Apolipoprotein E in High Density Lipoprotein Fraction by Immunofixation Method and Turbidimetric Immunoassay After Precipitation
Y Okamoto, H Tsujii, Y Haga, S Tanaka, H Nakano
Journal of Atherosclerosis and Thrombosis 1994
Properties of Human Plasma Lipid Transfer Protein in Aqueous Solution and at Interfaces
T Ohnishi, LD Hicks, K Oikawa, CM Kay, S Yokoyama
Biochemistry 1994
Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity
T Arai, S Yamashita, K Hirano, N Sakai, K Kotani, S Fujioka, S Nozaki, Y Keno, M Yamane, E Shinohara
Arteriosclerosis Thrombosis and Vascular Biology 1994
In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism
K Ikewaki, DJ Rader, LA Zech, HB Brewer
Journal of lipid research 1994
Identification of apolipoprotein B-100 low density lipoproteins, apolipoprotein B-48 remnants, and apolipoprotein E-rich high density lipoproteins in the mouse
HV de Silva, J Más-Oliva, JM Taylor, RW Mahley
Journal of lipid research 1994
Inhibition of cholesteryl ester transfer protein in normocholesterolemic and hypercholesterolemic hamsters: effects on HDL subspecies, quantity, and apolipoprotein distribution
GF Evans, WR Bensch, LD Apelgren, D Bailey, RF Kauffman, TF Bumol, SH Zuckerman
Journal of lipid research 1994
Dietary regulation of cholesterol esterase mRNA level in rat pancreas
J Brodt-Eppley, DY Hui
Journal of lipid research 1994
Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels
GW Melchior, CK Castle, RW Murray, WL Blake, DM Dinh, KR Marotti
The Journal of biological chemistry 1994
Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency
K Ikewaki, DJ Rader, T Sakamoto, M Nishiwaki, N Wakimoto, JR Schaefer, T Ishikawa, T Fairwell, LA Zech, H Nakamura
Journal of Clinical Investigation 1993
A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins
K Takahashi, XC Jiang, N Sakai, S Yamashita, K Hirano, H Bujo, H Yamazaki, J Kusunoki, T Miura, P Kussie
Journal of Clinical Investigation 1993
High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene
KJ Lackner, H Dieplinger, G Nowicka, G Schmitz
Journal of Clinical Investigation 1993
Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: Relationship to abnormalities in high-density lipoprotein
H Hiraoka, S Yamashita, Y Matsuzawa, M Kubo, S Nozaki, N Sakai, KI Hirano, S Kawata, S Tarui
Hepatology 1993
Elevated high density lipoprotein concentrations in heart transplant recipients are related to impaired plasma cholesteryl ester transfer and hepatic lipase activity
V Atger, T Leclerc, M Cambillau, R Guillemain, C Marti, N Moatti, A Girard
Atherosclerosis 1993
Function of cholesteryl ester transfer protein in reverse cholesterol transport
R McPherson
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1993
Mechanisms of high-density lipoprotein reduction after probucol treatment: Changes in plasma cholesterol esterification/transfer and lipase-activities
G Chiesa, S Michelagnoli, M Cassinotti, G Gianfranceschi, JP Werba, F Pazzucconi, CR Sirotori, G Franceschini
Metabolism 1993
Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias
A Iglesias, JA Contreras, M Martinez-Pardo, A Entrala, E Herrera, MA Lasunción
Clinica Chimica Acta 1993
Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population — relation between the mutation and hyperalphalipoproteinemia
K Hirano, S Yamashita, T Funahashi, N Sakai, M Menju, M Ishigami, H Hiraoka, K Kameda-Takemura, K Tokunaga, T Hoshino, K Kumasaka, K Kawano, Y Matsuzawa
Atherosclerosis 1993
Unusual high-density lipoprotein subclass distribution during late pregnancy
K Silliman, AR Tall, N Kretchmer, TM Forte
Metabolism 1993
Activation of human plasma lipid transfer protein by apolipoproteins
T Ohnishi, S Yokoyama
Biochemistry 1993
Determination of lipid transfer inhibitor protein activity in human lipoprotein-deficient plasma
RE Morton, JV Steinbrunner
Arteriosclerosis Thrombosis and Vascular Biology 1993
Advances in Human Genetics 21
H Harris, K Hirschhorn
1993
Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix
U Saxena, E Ferguson, CL Bisgaier
The Journal of biological chemistry 1993
Adipose tissue cholesteryl ester transfer protein mRNA in response to probucol treatment: cholesterol and species dependence
EM Quinet, P Huerta, D Nancoo, AR Tall, YL Marcel, R McPherson
Journal of lipid research 1993
Plasma cholesteryl ester transfer protein
AR Tall
Journal of lipid research 1993
An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels
T Hayek, T Chajek-Shaul, A Walsh, LB Agellon, P Moulin, AR Tall, JL Breslow
Journal of Clinical Investigation 1992
Metabolic and genetic control of HDL cholesterol levels
AR Tall
Journal of Internal Medicine 1992
Low-density lipoproteins in hyperalphalipoproteinemic heavy alcohol drinkers have reduced affinity for the low-density lipoprotein receptor
K Hirano, S Yamashita, N Sakai, H Hiraoka, Y Ueyama, T Funahashi, Y Matsuzawa
Clinical Biochemistry 1992
The CCAAT/enhancer-binding protein trans-activates the human cholesteryl ester transfer protein gene promoter
LB Agellon, P Zhang, XC Jiang, L Mendelsohn, AR Tall
The Journal of biological chemistry 1992
Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients
G Franceschini, G Chiesa, CR Sirtori
European Journal of Clinical Investigation 1991
Reverse cholesterol transport: Physiology and pharmacology
G Franceschini, P Maderna, CR Sirtori
Atherosclerosis 1991
The role of the cholesteryl ester transfer protein in lipoprotein metabolism
TL Swenson
Diabetes / Metabolism Reviews 1991
Role of cholesteryl ester transfer protein in reverse cholesterol transport
R Mcpherson, Y Marcel
Clinical Cardiology 1991
HDL heterogeneity and coronary heart disease
C Fievet, JC Fruchart
Diabetes / Metabolism Reviews 1991
Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: Plasma CETP regulates high-density lipoprotein concentration and composition
S Yamashita, DY Hui, JR Wetterau, DL Sprecher, JA Harmony, N Sakai, Y Matsuzawa, S Tarui
Metabolism 1991
1. Pathophysiology of triglyceride-rich particles
Y Stein, RJ Havel
The American Journal of Cardiology 1991
Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency
N Sakai, Y Matsuzawa, K Hirano, S Yamashita, S Nozaki, Y Ueyama, M Kubo, S Tarui
Arteriosclerosis Thrombosis and Vascular Biology 1991
Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables
R McPherson, CJ Mann, AR Tall, M Hogue, L Martin, RW Milne, YL Marcel
Arteriosclerosis Thrombosis and Vascular Biology 1991
Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice
LB Agellon, A Walsh, T Hayek, P Moulin, XC Jiang, SA Shelanski, JL Breslow, AR Tall
The Journal of biological chemistry 1991
New Comprehensive Biochemistry
S Yamamoto
New Comprehensive Biochemistry 1983

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts